GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » Days Sales Outstanding

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Days Sales Outstanding

: 37.02 (As of Dec. 2023)
View and export this data going back to . Start your Free Trial

Carl Zeiss Meditec AG's average Accounts Receivable for the three months ended in Dec. 2023 was $210 Mil. Carl Zeiss Meditec AG's Revenue for the three months ended in Dec. 2023 was $518 Mil. Hence, Carl Zeiss Meditec AG's Days Sales Outstanding for the three months ended in Dec. 2023 was 37.02.

The historical rank and industry rank for Carl Zeiss Meditec AG's Days Sales Outstanding or its related term are showing as below:

CZMWF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.48   Med: 52.96   Max: 62.72
Current: 45.46

During the past 13 years, Carl Zeiss Meditec AG's highest Days Sales Outstanding was 62.72. The lowest was 34.48. And the median was 52.96.

CZMWF's Days Sales Outstanding is ranked better than
75.9% of 809 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs CZMWF: 45.46

Carl Zeiss Meditec AG's Days Sales Outstanding increased from Dec. 2022 (35.87) to Dec. 2023 (37.02).

Carl Zeiss Meditec AG Days Sales Outstanding Historical Data

The historical data trend for Carl Zeiss Meditec AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Days Sales Outstanding
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.22 48.87 38.93 40.16 33.23

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.87 70.17 65.34 31.00 37.02
Competitive Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carl Zeiss Meditec AG Days Sales Outstanding Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Days Sales Outstanding falls into.


Carl Zeiss Meditec AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Carl Zeiss Meditec AG's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

Days Sales Outstanding (A: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2022 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (195.843 + 210.156) / 2 ) / 2229.776*365
=202.9995 / 2229.776*365
=33.23

Carl Zeiss Meditec AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (210.156 + 0) / 1 ) / 517.993*365 / 4
=210.156 / 517.993*365 / 4
=37.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG  (OTCPK:CZMWF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Carl Zeiss Meditec AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » Days Sales Outstanding
Comparable Companies
XTER:GXI XTER:FIE FRA:PHH2 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543 XSWX:STMN BAX COO HOLX TSE:7733 TSE:6869 TFX
Traded in Other Exchanges
CZMWY:USA 1AFX:Italy AFXd:UK 0DHC:UK AFX:Germany AFX:Austria
Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Website
https://www.zeiss.com
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.